Metraipolis › archive › dc_48864fb99de0

An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID — Europe PMC PMID:42063202

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42063202
DOI
10.1186/s40814-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-08T03:04:59.879Z
SHA-256 of the archived text
82bb2d902d97d7294aceaf4575f1ce3662198e042d0ee1f6aa9da84ffece4b80
Stable URL of this page
https://metraipolis.com/documento/dc_48864fb99de0

How to cite

An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID — Europe PMC PMID:42063202 — Europe PMC (en), https://europepmc.org/article/MED/42063202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48864fb99de0 (Metraipolis archive dc_48864fb99de0, sha256 82bb2d902d97d7294aceaf4575f1ce3662198e042d0ee1f6aa9da84ffece4b80)
BibTeX
@misc{dc48864fb99de0,
  title = {An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID — Europe PMC PMID:42063202},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42063202},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48864fb99de0; sha256 82bb2d902d97d7294aceaf4575f1ce3662198e042d0ee1f6aa9da84ffece4b80},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42063202. Agents can read the archived copy with the MCP tool read_document.